Navigation Links
Whitehead Member Rudolf Jaenisch to receive MGH's Warren Triennial Prize
Date:12/16/2010

CAMBRIDGE, Mass. (December 16, 2010) Whitehead Institute Founding Member Rudolf Jaenisch has been named a recipient of the 2011 Warren Triennial Prize of Massachusetts General Hospital (MGH).

By tradition, the prize is awarded to two scientists, and Jaenisch will share the prize with Dr. Shinya Yamanaka, who is on the faculty of both Kyoto University in Japan and the Gladstone Institutes in San Francisco.

"The Warren Prize is the top scientific award presented by the MGH, and we are delighted to be able to honor the groundbreaking work of Drs. Yamanaka and Jaenisch," says Daniel Haber, MD, chair of the MGH Executive Committee on Research and director of the MGH Cancer Center. "Their research has opened up a new direction for the future of medicine, which is particularly appropriate at a time when we are commemorating the scientific leadership the MGH has displayed throughout its history."

"I am very honored and particularly pleased to be awarded this prize with Yamanaka, who has made such important contributions to this field," says Jaenisch, who is also a professor of biology at MIT.

In 2006 Yamanaka created a new type of cell, the induced pluripotent stem (iPS) cell. By adding four transcription factors to adult skin cells, Yamanaka reprogrammed the cells to an embryonic stem cell-like state. Working with these iPS cells, Yamanaka showed that they are able to give rise to almost any type of mammalian cell.

Both Jaenisch and Yamanaka reported growing live mice from iPS cells in 2007. Jaenisch then pushed to realize iPS cells' therapeutic potential by correcting sickle cell anemia in mice and treating Parkinson's disease in rats. Earlier this year, Jaenisch reprogrammed human blood cells into iPS cells that could be used to study hematological diseases. Jaenisch has also continued his work with human embryonic stem cells, to understand and overcome these cells' limitations for use in regenerative biology.

"This prize recognizes what we've known for years: that Rudolf is absolutely and consistently at the forefront and has been for years a pioneer in the science of cellular reprogramming and in establishing its application in the treatment of human disease," says Whitehead Institute Director David Page, who notes that prior to the discovery of methods to create iPS cells, Jaenisch used a technique known as somatic cell nuclear transfer in an unprecedented proof-of-principle experiment to correct genetic defects in mouse models of immunodeficiency.

Jaenisch is the third Whitehead Member to receive the Warren Prize. Founding Director David Baltimore won the award in 1971, as did Founding Member Robert Weinberg in 1983.


'/>"/>

Contact: Nicole Giese
giese@wi.mit.edu
617-258-6851
Whitehead Institute for Biomedical Research
Source:Eurekalert

Related biology news :

1. Whitehead member Peter Reddien named HHMI Early Career Scientist
2. Circadian clock may be critical for remembering what you learn, Stanford researchers say
3. Old and young brains rely on different systems to remember emotional content
4. 13 UCR faculty members recognized by American Association for the Advancement of Science
5. UT faculty members win American Heart Association awards for advancing research
6. Springer author and advisory board member wins LOreal UNESCO Women in Science Award
7. NIH Clinical and Translational Science Consortium grows to 39 members
8. Open-access membership: Reporting tool brings convenience and control
9. You must remember this: Scientists develop nasal spray that improves memory
10. St. Jude faculty member named American Association for the Advancement of Science 2009 Fellow
11. Members of Congress, university leaders, scientists launch ScienceWorksForUS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
(Date:4/14/2016)... 2016 BioCatch ™, the ... announced the appointment of Eyal Goldwerger as ... Goldwerger,s leadership appointment comes at a time of ... deployment of its platform at several of the world,s ... discerns unique cognitive and physiological factors, is a winner ...
(Date:3/31/2016)... , March 31, 2016 ... ) ("LegacyXChange" or the "Company") LegacyXChange is ... users of its soon to be launched online site ... https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential shareholders ... of DNA technology to an industry that is notorious ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... ... ... STACS DNA Inc., the sample tracking software company, today announced that Dr. ... STACS DNA as a Field Application Specialist. , “I am thrilled that Dr. ... STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings a ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... June 23, 2016 ... 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 Published recently ... peer-reviewed journal from touchONCOLOGY, Andrew D Zelenetz ... of cancer care is placing an increasing burden ... expensive biologic therapies. With the patents on many ...
Breaking Biology Technology: